Urinary Tract Infection(UTI)NCT07246837
Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care
A study testing MSCC Educational Tool in people with Urinary Tract Infection(UTI) and Antimicrobial Stewardship, run by Baylor College of Medicine at 1 site in United States.
Trial summary
Urine culture is the most common microbiological test in the outpatient setting in the United States. Unfortunately, contamination during collection is prevalent and undermines test accuracy, leading to incorrect diagnosis, unnecessary treatment, wasted laboratory resources, and inflated costs. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Urinary Tract Infection(UTI), Antimicrobial Stewardship, Primary Care
- What is being tested?
- MSCC Educational Tool
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 252 participants
- Where
- 1 siteUnited States
- Study dates
- 22 Jan 2026to 31 May 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults (≥18 years) undergoing urine culture as part of routine outpatient care
- Able to provide informed consent
- English- and or Spanish-speaking.
Who cannot join
- Presence of a urinary catheter
- Inability to read and sign the informed consent
- Unable to follow study procedures (due to significant visual, auditory, physical or cognitive impairment).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Baylor College of Medicine
Houston, Texas, 77098
Kiara Olmeda, 7137983293, kiara.olmeda@bcm.edu
About this study
Official title: A Randomized Controlled Trial of a Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care
Urine culture is the most common microbiological test in the outpatient setting in the United States. Unfortunately, contamination during collection is prevalent and undermines test accuracy, leading to incorrect diagnosis, unnecessary treatment, wasted laboratory resources, and inflated costs. Unnecessary antibiotic treatment increases the risk of developing antimicrobial resistance, one of the most serious threats to patients and public health. The goal of this clinical trial is to test whether a bilingual (English and Spanish) educational intervention, an animated video and pictorial flyer, can reduce urine culture contamination and associated inappropriate antibiotic use in adult patients visiting safety-net primary care clinics.
The main questions it aims to answer are:
- Does providing patients with a bilingual educational intervention reduce urine culture contamination rates?
- Does the intervention lead to fewer unnecessary urinary antibiotic prescriptions?
- Does providing patients with a bilingual educational intervention reduce contaminated urinalyses? Researchers will compare patients randomized to receive the educational intervention (video and flyer) to those receiving usual care to see if the intervention improves urine collection accuracy and reduces inappropriate antibiotic use. Participants will watch a short, animated video with step-by-step instructions for proper midstream clean-catch urine (MSCC) collection, receive a pictorial flyer (with stills from the video) reinforcing the instructions, and provide a urine sample for culture. Hypothesis: patients who receive the educational intervention will have: lower urine culture contamination rates (primary outcome), fewer urinary antibiotic prescriptions (secondary outcome), and fewer contaminated urinalyses (secondary outcome). The objectives are to (1) develop educational tools: Create an animated video and pictorial flyer with step-by-step urine collection instructions for women and men, developed through an iterative, stakeholder-engaged process, (2) assess acceptability: Use mixed methods (quantitative surveys and qualitative interviews) to evaluate and refine the tools for usability and cultural/linguistic appropriateness, and (3) test effectiveness: Conduct a randomized controlled trial to assess the intervention's impact on urine contamination rates, antibiotic prescribing, and patient satisfaction.
Read the detailed description
Background: Urinary tract infections (UTIs) account for more than 10 million ambulatory visits annually in the United States and are the third-leading cause of outpatient antibiotic prescriptions. Gram-negative urinary pathogens collected from outpatients across all regions of the United States now exhibit antimicrobial resistance levels that exceed thresholds recommended for empiric treatment of UTIs. Accurate urine cultures are essential for guiding antibiotic therapy. Midstream clean-catch (MSCC) urine collection is the gold standard for obtaining urine specimens, yet contamination rates in outpatient settings range from 46% to 55% in the recent studies. Contamination leads to incorrect diagnoses, unnecessary antibiotic use, increased resistance, and higher healthcare costs. Prior interventions aimed at reducing contamination have had mixed results and lacked stakeholder engagement and effective educational modalities.
Significance: This study addresses Goal 3 of the National Action Plan for Combating Antibiotic-Resistant Bacteria and CDC priorities by improving diagnostic accuracy and reducing inappropriate antibiotic use. Our approach empowers frontline staff and targets a neglected area of outpatient diagnostic stewardship. Urine culture contamination is common, wasteful, and harmful, particularly for pregnant patients who are routinely screened for bacteriuria. Contamination obscures true infection or leads to overtreatment, increasing risks for antimicrobial resistance, adverse drug reactions, and healthcare costs. Our intervention will improve patient care and reduce waste of laboratory resources.
Innovation and Impact: The proposed research is innovative because it places nurses and medical assistants at the forefront of antimicrobial stewardship in primary care. The investigators will develop a bilingual, multicultural educational intervention that includes an animated instructional video and a pictorial flyer. These materials will provide step-by-step guidance for proper MSCC urine collection and will be designed with input from patients, nurses, and medical assistants to ensure cultural competence and clarity for individuals with low literacy. This approach represents a departure from previous interventions, which lacked stakeholder engagement and failed to reduce contamination rates effectively. By incorporating stakeholder feedback and using engaging visual formats, the investigators aim to create an intervention that is acceptable, appropriate, and feasible for diverse patient populations.
Specific Aims: Aim 1: Iteratively develop a bilingual, multicultural educational intervention to reduce urine contamination, with stakeholder and expert input. The intervention will include an animated instructional video and a flyer with pictorial instructions that will provide step-by-step guidance to patients for collecting an MSCC urine sample. Aim 2: Perform a pilot study to assess and improve the intervention's acceptability, appropriateness, and feasibility using mixed methods. The investigators will use a sequential explanatory design that includes a quantitative survey and qualitative interviews with stakeholders (patients, nurses, and medical assistants). Aim 3: Test the effectiveness of the intervention at reducing urine culture contamination via a randomized controlled trial. The investigators hypothesize that patients who are randomized to receive the intervention versus usual care will have lower culture contamination rates (primary outcome), fewer urinary antibiotic prescriptions (secondary outcome), and fewer contaminated urinalyses (secondary outcome). Investigators will also study intervention fidelity, usability, and patient satisfaction using mixed methods research.
Methodology: The study will be conducted in two safety-net and one private primary care clinics. The investigators will use a randomized controlled trial with parallel groups to compare the intervention to usual care. Eligible participants will be adults aged 18 years or older who are asked to provide a urine sample for culture or urinalysis. Patients with indwelling urinary catheters or those unable to view the video or read the flyer in English or Spanish will be excluded. Randomization will occur at the patient level using a secure electronic system managed through REDCap. Participants assigned to the intervention group will view the animated video and flyer in their preferred language before urine collection. Men will receive materials tailored for men, and women will receive materials tailored for women. Participants in the control group will receive usual care without additional education. The primary outcome is the proportion of contaminated urine cultures, defined as mixed flora, growth of non-uropathogens, or growth of three or more uropathogens. Secondary outcomes include antibiotic prescribing within seven days of urine culture results and contamination of urinalyses, defined as more than ten squamous epithelial cells per microscopic field. The investigators will also assess implementation results through exit interviews and surveys. The sample size for the trial is 252 patients (126 per arm). Data will be collected from electronic medical records, patient surveys, and qualitative interviews. All data will be securely stored and de-identified for analysis.
Next Steps/Implementation: If the intervention proves effective, future work will focus on disseminating the educational tools to other settings, such as emergency departments and long-term care facilities. This project will provide a scalable, resource-efficient approach to improving diagnostic accuracy, reducing unnecessary antibiotic use, and advancing antimicrobial stewardship in outpatient care.
- Being tested
- MSCC Educational Tool
- Keywords
- Urinary Tract Infection, UTI, Inappropriate Antibiotic Use, Diagnostic Stewardship, Antibiotic Resistance, Antimicrobial Stewardship, Primary Care, Randomized Controlled Trial
- Medical subject headings
- Urinary Tract Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MSCC Educational ToolBehavioural
A brief educational intervention (video + flyer) designed to improve urine collection technique and reduce contamination. Delivered in the patient's preferred language (English or Spanish) immediately before urine collection.
| Study group | Role | What they receive |
|---|---|---|
| MSCC Educational Tool | Experimental | Participants receive a standardized educational tool prior to urine collection. This includes a short video and flyer in English or Spanish explaining proper midstream clean-catch technique. Materials are shown in the exam room before specimen collection. Receives: Behavioral: MSCC Educational Tool |
| Usual Care | No intervention | Participants receive standard clinical care without additional educational materials. Urine collection follows routine clinic procedures. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Urine Culture Contamination
Presence of mixed flora, growth of non-uropathogens, or growth of three or more uropathogens in urine culture results.
Measured: Within 48 hours of specimen collection
Secondary outcomes (3)
Contaminated Urinalysis Status
Urine specimen will be considered contaminated if laboratory analysis reports 10 or more epithelial cells per high-power field.
Measured: Within 24-48 hours of specimen collection
Antibiotic Use
Antibiotic prescriptions associated with urine culture results.
Measured: Within 7 days post-collection
Patient Understanding and Satisfaction
Exit interviews assessing comprehension of collection steps, intervention fidelity and usability, and satisfaction with instructions. This survey will be completed with patients who received the intervention.
Measured: Immediately post-collection and after clinic visit.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Nov 2025
- Study start22 Jan 2026
- Primary completion1 Sep 2026 (estimated)
- Study completion31 May 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Urinary Tract Infection(UTI)Studies of the same condition, open and under way.
- More trials run by Baylor College of MedicineThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomly assigned in a 1:1 ratio to either the intervention group or the control group. The intervention group will receive a standardized educational tool, including a short video and flyer in English or Spanish, before urine collection to improve midstream clean-catch technique. The control group will receive usual care without additional education. All participants will collect urine samples using standard clinic materials, and samples will be processed according to routine laboratory protocols. The primary outcome is urine contamination status based on laboratory findings of epithelial cells or mixed flora. Secondary outcomes include antibiotic prescribing patterns, patient understanding of collection steps, and satisfaction with instructions. Randomization will be managed through REDCap. The study is open-label, and participation is voluntary with no impact on clinical care.
- Masking
- None (open label)
- Enrolment
- 252 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Baylor College of Medicine
- Sponsor type
- University, hospital or other
- Collaborators
- Washington University School of Medicine
- Responsible party
- Principal investigator, LarisaGrigoryan, Baylor College of Medicine
- Investigators
- Larissa Grigoryan, MD, PhD, Principal investigator, Baylor College of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07246837
- Sponsor's protocol ID
- H-53559
- Other IDs
- R01HS029489
- Status last verified
- Feb 2026
- First submitted
- 19 Nov 2025
- Last updated
- 13 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared because participants did not provide consent for data sharing beyond the scope of this study, and sharing could compromise confidentiality despite de-identification efforts.
Publications
Bekeris LG, Jones BA, Walsh MK, Wagar EA. Urine culture contamination: a College of American Pathologists Q-Probes study of 127 laboratories. Arch Pathol Lab Med. 2008 Jun;132(6):913-7. doi: 10.5858/2008-132-913-UCCACO.
PubMed 18517272Goebel MC, Trautner BW, Grigoryan L. The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections. Clin Microbiol Rev. 2021 Dec 15;34(4):e0000320. doi: 10.1128/CMR.00003-20. Epub 2021 Aug 25.
PubMed 34431702Hansen MA, Valentine-King M, Zoorob R, Schlueter M, Matas JL, Willis SE, Danek LCK, Muldrew KL, Zare M, Hudson F, Atmar RL, Chou A, Trautner BW, Grigoryan L. Prevalence and predictors of urine culture contamination in primary care: A cross-sectional study. Int J Nurs Stud. 2022 Oct;134:104325. doi: 10.1016/j.ijnurstu.2022.104325. Epub 2022 Jul 11.
PubMed 35914376Gupta K, Grigoryan L, Trautner B. Urinary Tract Infection. Ann Intern Med. 2017 Oct 3;167(7):ITC49-ITC64. doi: 10.7326/AITC201710030.
PubMed 28973215
Study at a glance
From the registry record, last updated by the sponsor on 13 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Trial of a Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care
- ClinicalTrials.gov ID
- NCT07246837
- Acronym / sponsor ID
- H-53559
- Keywords
- Urinary Tract Infection, UTI, Inappropriate Antibiotic Use, Diagnostic Stewardship, Antibiotic Resistance, Antimicrobial Stewardship, Primary Care, Randomized Controlled Trial
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 252 participants (estimated)
- Lead sponsor
- Baylor College of MedicineUniversity, hospital or other
- Collaborators
- Washington University School of Medicine
- Study start
- 22 Jan 2026 (actual)
- Primary completion
- 1 Sep 2026 (estimated)
- Study completion
- 31 May 2028 (estimated)
- First posted
- 24 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Urine culture is the most common microbiological test in the outpatient setting in the United States. Unfortunately, contamination during collection is prevalent and undermines test accuracy, leading to incorrect diagnosis, unnecessary treatment, wasted laboratory resources, and inflated costs. Unnecessary antibiotic treatment increases the risk of developing antimicrobial resistance, one of the most serious threats to patients and public health. The goal of this clinical trial is to test whether a bilingual (English and Spanish) educational intervention, an animated video and pictorial flyer, can reduce urine culture contamination and associated inappropriate antibiotic use in adult patients visiting safety-net primary care clinics.
The main questions it aims to answer are:
- Does providing patients with a bilingual educational intervention reduce urine culture contamination rates?
- Does the intervention lead to fewer unnecessary urinary antibiotic prescriptions?
- Does providing patients with a bilingual educational intervention reduce contaminated urinalyses? Researchers will compare patients randomized to receive the educational intervention (video and flyer) to those receiving usual care to see if the intervention improves urine collection accuracy and reduces inappropriate antibiotic use. Participants will watch a short, animated video with step-by-step instructions for proper midstream clean-catch urine (MSCC) collection, receive a pictorial flyer (with stills from the video) reinforcing the instructions, and provide a urine sample for culture. Hypothesis: patients who receive the educational intervention will have: lower urine culture contamination rates (primary outcome), fewer urinary antibiotic prescriptions (secondary outcome), and fewer contaminated urinalyses (secondary outcome). The objectives are to (1) develop educational tools: Create an animated video and pictorial flyer with step-by-step urine collection instructions for women and men, developed through an iterative, stakeholder-engaged process, (2) assess acceptability: Use mixed methods (quantitative surveys and qualitative interviews) to evaluate and refine the tools for usability and cultural/linguistic appropriateness, and (3) test effectiveness: Conduct a randomized controlled trial to assess the intervention's impact on urine contamination rates, antibiotic prescribing, and patient satisfaction.
Detailed description
Background: Urinary tract infections (UTIs) account for more than 10 million ambulatory visits annually in the United States and are the third-leading cause of outpatient antibiotic prescriptions. Gram-negative urinary pathogens collected from outpatients across all regions of the United States now exhibit antimicrobial resistance levels that exceed thresholds recommended for empiric treatment of UTIs. Accurate urine cultures are essential for guiding antibiotic therapy. Midstream clean-catch (MSCC) urine collection is the gold standard for obtaining urine specimens, yet contamination rates in outpatient settings range from 46% to 55% in the recent studies. Contamination leads to incorrect diagnoses, unnecessary antibiotic use, increased resistance, and higher healthcare costs. Prior interventions aimed at reducing contamination have had mixed results and lacked stakeholder engagement and effective educational modalities.
Significance: This study addresses Goal 3 of the National Action Plan for Combating Antibiotic-Resistant Bacteria and CDC priorities by improving diagnostic accuracy and reducing inappropriate antibiotic use. Our approach empowers frontline staff and targets a neglected area of outpatient diagnostic stewardship. Urine culture contamination is common, wasteful, and harmful, particularly for pregnant patients who are routinely screened for bacteriuria. Contamination obscures true infection or leads to overtreatment, increasing risks for antimicrobial resistance, adverse drug reactions, and healthcare costs. Our intervention will improve patient care and reduce waste of laboratory resources.
Innovation and Impact: The proposed research is innovative because it places nurses and medical assistants at the forefront of antimicrobial stewardship in primary care. The investigators will develop a bilingual, multicultural educational intervention that includes an animated instructional video and a pictorial flyer. These materials will provide step-by-step guidance for proper MSCC urine collection and will be designed with input from patients, nurses, and medical assistants to ensure cultural competence and clarity for individuals with low literacy. This approach represents a departure from previous interventions, which lacked stakeholder engagement and failed to reduce contamination rates effectively. By incorporating stakeholder feedback and using engaging visual formats, the investigators aim to create an intervention that is acceptable, appropriate, and feasible for diverse patient populations.
Specific Aims: Aim 1: Iteratively develop a bilingual, multicultural educational intervention to reduce urine contamination, with stakeholder and expert input. The intervention will include an animated instructional video and a flyer with pictorial instructions that will provide step-by-step guidance to patients for collecting an MSCC urine sample. Aim 2: Perform a pilot study to assess and improve the intervention's acceptability, appropriateness, and feasibility using mixed methods. The investigators will use a sequential explanatory design that includes a quantitative survey and qualitative interviews with stakeholders (patients, nurses, and medical assistants). Aim 3: Test the effectiveness of the intervention at reducing urine culture contamination via a randomized controlled trial. The investigators hypothesize that patients who are randomized to receive the intervention versus usual care will have lower culture contamination rates (primary outcome), fewer urinary antibiotic prescriptions (secondary outcome), and fewer contaminated urinalyses (secondary outcome). Investigators will also study intervention fidelity, usability, and patient satisfaction using mixed methods research.
Methodology: The study will be conducted in two safety-net and one private primary care clinics. The investigators will use a randomized controlled trial with parallel groups to compare the intervention to usual care. Eligible participants will be adults aged 18 years or older who are asked to provide a urine sample for culture or urinalysis. Patients with indwelling urinary catheters or those unable to view the video or read the flyer in English or Spanish will be excluded. Randomization will occur at the patient level using a secure electronic system managed through REDCap. Participants assigned to the intervention group will view the animated video and flyer in their preferred language before urine collection. Men will receive materials tailored for men, and women will receive materials tailored for women. Participants in the control group will receive usual care without additional education. The primary outcome is the proportion of contaminated urine cultures, defined as mixed flora, growth of non-uropathogens, or growth of three or more uropathogens. Secondary outcomes include antibiotic prescribing within seven days of urine culture results and contamination of urinalyses, defined as more than ten squamous epithelial cells per microscopic field. The investigators will also assess implementation results through exit interviews and surveys. The sample size for the trial is 252 patients (126 per arm). Data will be collected from electronic medical records, patient surveys, and qualitative interviews. All data will be securely stored and de-identified for analysis.
Next Steps/Implementation: If the intervention proves effective, future work will focus on disseminating the educational tools to other settings, such as emergency departments and long-term care facilities. This project will provide a scalable, resource-efficient approach to improving diagnostic accuracy, reducing unnecessary antibiotic use, and advancing antimicrobial stewardship in outpatient care.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants will be randomly assigned in a 1:1 ratio to either the intervention group or the control group. The intervention group will receive a standardized educational tool, including a short video and flyer in English or Spanish, before urine collection to improve midstream clean-catch technique. The control group will receive usual care without additional education. All participants will collect urine samples using standard clinic materials, and samples will be processed according to routine laboratory protocols. The primary outcome is urine contamination status based on laboratory findings of epithelial cells or mixed flora. Secondary outcomes include antibiotic prescribing patterns, patient understanding of collection steps, and satisfaction with instructions. Randomization will be managed through REDCap. The study is open-label, and participation is voluntary with no impact on clinical care.
| Arm | Type | Receives |
|---|---|---|
| MSCC Educational Tool | Experimental | Behavioral: MSCC Educational ToolParticipants receive a standardized educational tool prior to urine collection. This includes a short video and flyer in English or Spanish explaining proper midstream clean-catch technique. Materials are shown in the exam room before specimen collection. |
| Usual Care | No intervention | –Participants receive standard clinical care without additional educational materials. Urine collection follows routine clinic procedures. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Adults (≥18 years) undergoing urine culture as part of routine outpatient care
- Able to provide informed consent
- English- and or Spanish-speaking.
Key exclusion criteria (3 listed)
- Presence of a urinary catheter
- Inability to read and sign the informed consent
- Unable to follow study procedures (due to significant visual, auditory, physical or cognitive impairment).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MSCC Educational ToolA brief educational intervention (video + flyer) designed to improve urine collection technique and reduce contamination. Delivered in the patient's preferred language (English or Spanish) immediately before urine collection. | Behavioural | MSCC Educational Tool |
Primary outcome
Urine Culture Contamination
Time frame: Within 48 hours of specimen collection
Presence of mixed flora, growth of non-uropathogens, or growth of three or more uropathogens in urine culture results.
3 secondary outcomes
Contaminated Urinalysis Status
Time frame: Within 24-48 hours of specimen collection
Antibiotic Use
Time frame: Within 7 days post-collection
Patient Understanding and Satisfaction
Time frame: Immediately post-collection and after clinic visit.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Feb 2026.
- Background: PubMed 18517272Bekeris LG, Jones BA, Walsh MK, Wagar EA. Urine culture contamination: a College of American Pathologists Q-Probes study of 127 laboratories. Arch Pathol Lab Med. 2008 Jun;132(6):913-7. doi: 10.5858/2008-132-913-UCCACO.
- Background: PubMed 34431702Goebel MC, Trautner BW, Grigoryan L. The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections. Clin Microbiol Rev. 2021 Dec 15;34(4):e0000320. doi: 10.1128/CMR.00003-20. Epub 2021 Aug 25.
- Background: PubMed 35914376Hansen MA, Valentine-King M, Zoorob R, Schlueter M, Matas JL, Willis SE, Danek LCK, Muldrew KL, Zare M, Hudson F, Atmar RL, Chou A, Trautner BW, Grigoryan L. Prevalence and predictors of urine culture contamination in primary care: A cross-sectional study. Int J Nurs Stud. 2022 Oct;134:104325. doi: 10.1016/j.ijnurstu.2022.104325. Epub 2022 Jul 11.
- Background: PubMed 28973215Gupta K, Grigoryan L, Trautner B. Urinary Tract Infection. Ann Intern Med. 2017 Oct 3;167(7):ITC49-ITC64. doi: 10.7326/AITC201710030.
- Individual participant dataSharing planned: No. Individual participant data will not be shared because participants did not provide consent for data sharing beyond the scope of this study, and sharing could compromise confidentiality despite de-identification efforts.
Related trials for Urinary Tract Infection(UTI)
Recruiting
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
Urinary Tract Infections
Active, not recruitingObservational study
Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR
Complicated Urinary Tract Infection
Recruiting
INterest of the Negative Predictive Value of Integrons in the reduCtion of Large Broad-spectrum anTibiotics Consumption for Urinary Tract infectionS
Drug Resistance, Microbial, Biomarkers
Not yet recruitingObservational study
Comparative Study of the Genomic Characteristics of Uropathogenic Escherichia Coli According to the Severity of Community-Acquired Urinary Tract Infections in Guadeloupe (COLIGENURI)
Urinary Tract Infections
Active, not recruitingObservational study
Characterization of Vaginal, Urinary and Fecal Microbiomes in Women With Recurrent Urinary Tract Infections
Urinary Tract Infections, Menopause
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Larissa Grigoryan, MD, PhD principal investigator
Baylor College of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing MSCC Educational Tool in people with Urinary Tract Infection(UTI) and Antimicrobial Stewardship, run by Baylor College of Medicine at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Kiara Olmeda, MS (7137983293, kiara.olmeda@bcm.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Urine Culture Contamination (time frame: Within 48 hours of specimen collection). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07246837, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026.